Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

For advancements to be made in pathophysiology and medication development of Parkinson’s disease, reliable disease models need ... By consistently adapting to new regulatory challenges and guidelines, ...

The earlier Parkinson's disease is spotted, the better – for patients, their loved ones, and scientists working toward ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating whether Ambroxol - a cough medicine used safely for decades in Europe - can ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Scientists have achieved a major breakthrough in Parkinson's disease research, identifying a brain protein that may unlock new possibilities for treatment, a new research has revealed.

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...